You are here

nerandomilast

Boehringer details data from pair of Phase III pulmonary fibrosis wins

First Word Pharma

Mon, 05/19/25 - 10:28 pm

Boehringer Ingelheim

pulmonary fibrosis

clinical trials

Boehringer seeks approval of lung disease drug after second Phase III success

Clinical Trials Arena

Mon, 02/10/25 - 10:20 pm

Boehinger Ingelheim

progressive fibrosing interstitial lung diseases

Boehringer widens fibrosis drug’s approval path after boosting lung function in 2nd phase 3 trial

Fierce Biotech

Mon, 02/10/25 - 11:52 am

Boehinger Ingelheim

clinical trials

Boehringer's phase 3 lung fibrosis trial hits primary endpoint, teeing up filings for Ofev successor

Fierce Biotech

Mon, 09/16/24 - 10:57 am

Boehringer Ingelheim

clinical trials